RevMAb Biosciences USA
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
863 Mitten Rd Ste 104, Burlingame, Calif...Phone Number
(650) 351-7325Website
www.revmab.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About RevMAb Biosciences USA
RevMAb specializes in the development of recombinant monoclonal antibodies, utilizing a revolutionary method that bypasses traditional hybridoma technology. Their product range includes a variety of primary and secondary antibodies, as well as custom services for therapeutic and diagnostic antibody discovery. The company targets clients in research, diagnostics, and therapeutic sectors, providing high-quality antibodies for various applications. RevMAb is committed to advancing antibody technology and offers a wide selection of products tailored to meet specific research needs.Explore more
RevMAb Biosciences USA Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RevMAb Biosciences USA your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once RevMAb Biosciences USA has new funding data
Check if RevMAb Biosciences USA has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at RevMAb Biosciences USA
RevMAb Biosciences USA, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if RevMAb Biosciences USA is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if RevMAb Biosciences USA had a recent Job posting/layoffs
Earning: See what the market has to say on RevMAb Biosciences USA recently announced quarterly report
Product Launch: Get notified when RevMAb Biosciences USA launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to RevMAb Biosciences USA
Compare insights from companies similar to RevMAb Biosciences USA, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
11-50
Private
-
2000
JH
Jun HayashiPresident of Precision Antibody, Vice President of A & G Pharmaceutical Inc
Company Profile Activity
Activity Insights
RevMAb Biosciences USA is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
RevMAb Biosciences USA is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about RevMAb Biosciences USA.
RevMAb Biosciences USA financials insights
Gather financial insights about RevMAb Biosciences USA, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
RevMAb Biosciences USA Tech Stack
A closer look at the technologies used by RevMAb Biosciences USA
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RevMAb Biosciences USA
Sign Up For FreeTo access detailed company insights
RevMAb specializes in the development of recombinant monoclonal antibodies, utilizing a revolutionary method that bypasses traditional hybridoma technology. Their product range includes a variety of primary and secondary antibodies, as well as custom services for therapeutic and diagnostic antibody discovery. The company targets clients in research... Read More
